Precision medicine may be health care's next big thing, but we don't yet know how to evaluate precision drugs - Quartz

QuartzPrecision medicine may be health care's next big thing, but we don't yet know how to evaluate precision drugsQuartzAn op-ed published Oct. 24 in the Journal of the American Medical Association, coauthored by Aaron Kesselheim, an associate professor of medicine at Harvard Medical School and a member of the FDA's Exondys 51 advisory committee, said the agency's ...